Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk
Authors
Keywords
-
Journal
AGEING RESEARCH REVIEWS
Volume 80, Issue -, Pages 101696
Publisher
Elsevier BV
Online
2022-07-15
DOI
10.1016/j.arr.2022.101696
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening, diagnosis and monitoring of sarcopenia: When to use which tool?
- (2022) Leanne L.G.C. Ackermans et al. Clinical Nutrition ESPEN
- Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
- (2022) Rocío Gallego-Durán et al. Scientific Reports
- Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
- (2022) Sara Naimimohasses et al. BMJ Open Gastroenterology
- Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα
- (2021) Tamaki Kurosawa et al. Cell Death & Disease
- Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study
- (2021) Yu-Ming Wang et al. BMC Geriatrics
- Sarcopenia in nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality in the United States
- (2021) Donghee Kim et al. LIVER INTERNATIONAL
- Characterization of the gut‐liver‐muscle axis in cirrhotic patients with sarcopenia
- (2021) Francesca Romana Ponziani et al. LIVER INTERNATIONAL
- Estradiol deficiency and skeletal muscle apoptosis: Possible contribution of microRNAs
- (2021) Sira Karvinen et al. EXPERIMENTAL GERONTOLOGY
- Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease
- (2021) Mohammad Shafi Kuchay et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey
- (2021) Jihye Hong et al. Metabolic Syndrome and Related Disorders
- Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults
- (2021) Xingxing Sun et al. Scientific Reports
- Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
- (2021) Taeang Arai et al. Scientific Reports
- Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
- (2021) Joon Ho Moon et al. Journal of Cachexia Sarcopenia and Muscle
- Understanding the gut microbiota and sarcopenia: a systematic review
- (2021) Chaoran Liu et al. Journal of Cachexia Sarcopenia and Muscle
- Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
- (2021) Ho Soo Chun et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia: What Is the Origin of This Aging-Induced Disorder?
- (2021) Thomas Gustafsson et al. Frontiers in Genetics
- Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis
- (2021) Liyuan Feng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery
- (2021) José Ignacio Martínez‐Montoro et al. Obesity Reviews
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis
- (2021) Fanny Petermann‐Rocha et al. Journal of Cachexia Sarcopenia and Muscle
- Metabolic reprogramming during hyperammonemia targets mitochondrial function and postmitotic senescence
- (2021) Avinash Kumar et al. JCI Insight
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
- (2020) Eugene Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease
- (2020) Qian Chen et al. ATHEROSCLEROSIS
- Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice
- (2020) Azar Asadi Shahmirzadi et al. Cell Metabolism
- Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease
- (2020) Chelsea S. Pan et al. CLINICAL ENDOCRINOLOGY
- Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review
- (2020) Paresh Dandona et al. DIABETES OBESITY & METABOLISM
- Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
- (2020) Giljae Lee et al. Nature Communications
- Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study
- (2020) Mingyuan Zhao et al. Scientific Reports
- Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease
- (2020) Yun‐Cheng Hsieh et al. LIVER INTERNATIONAL
- Sarcopenia, Diet, Physical Activity and Obesity in European Middle-Aged and Older Adults: The LifeAge Study
- (2020) Pablo Jorge Marcos-Pardo et al. Nutrients
- Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease
- (2019) Min Kyu Kang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation
- (2019) Wanda Delogu et al. DIGESTIVE AND LIVER DISEASE
- Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study
- (2019) Beom-Jun Kim et al. Aging-US
- Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2019) Changzhou Cai et al. Hepatology International
- Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association
- (2019) Andrew A. Li et al. Hepatobiliary Surgery and Nutrition
- Ammonia scavenging prevents progression of fibrosis in experimental non‐alcoholic fatty liver disease
- (2019) Francesco De Chiara et al. HEPATOLOGY
- Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion
- (2019) Peter Lykke Eriksen et al. LIVER INTERNATIONAL
- Sarcopenia and fatty liver disease
- (2019) Jung A. Kim et al. Hepatology International
- Low Testosterone Is Associated With Nonalcoholic Steatohepatitis (NASH) and Severity of NASH Fibrosis in Men With NAFLD
- (2019) Monika Sarkar et al. Clinical Gastroenterology and Hepatology
- Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
- (2018) Rui Yu et al. BMC GASTROENTEROLOGY
- Does nutrition play a role in the prevention and management of sarcopenia?
- (2018) S.M. Robinson et al. CLINICAL NUTRITION
- Relationship between relative skeletal muscle mass and non-alcoholic fatty liver disease: A 7-year longitudinal study
- (2018) Gyuri Kim et al. HEPATOLOGY
- The role of the microbiome in NAFLD and NASH
- (2018) Aleksandra A Kolodziejczyk et al. EMBO Molecular Medicine
- Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study
- (2017) Jae Seung Chang et al. Geriatrics & Gerontology International
- Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis
- (2017) Avinash Kumar et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
- (2017) Bo Kyung Koo et al. JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis
- (2017) Hiroki Nishikawa et al. Journal of Cachexia Sarcopenia and Muscle
- The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action
- (2016) O. Ethgen et al. CALCIFIED TISSUE INTERNATIONAL
- Testosterone Deficiency and Testosterone Treatment in Older Men
- (2016) Farid Saad et al. GERONTOLOGY
- A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease
- (2016) Jagpal Singh Klair et al. HEPATOLOGY
- Sarcopenia from mechanism to diagnosis and treatment in liver disease
- (2016) Srinivasan Dasarathy et al. JOURNAL OF HEPATOLOGY
- Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress
- (2016) Gangarao Davuluri et al. JOURNAL OF PHYSIOLOGY-LONDON
- Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
- (2016) Eleonora Poggiogalle et al. PLoS One
- Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD
- (2016) Johannie du Plessis et al. PLoS One
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)
- (2015) Yong-ho Lee et al. JOURNAL OF HEPATOLOGY
- Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
- (2015) Clemens Becker et al. Lancet Diabetes & Endocrinology
- Pharmacological Inhibition of Myostatin and Changes in Lean Body Mass and Lower Extremity Muscle Size in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2014) Desmond Padhi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014
- (2014) John E. Morley et al. Journal of Cachexia Sarcopenia and Muscle
- Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
- (2013) Y. Zhang et al. DIABETES
- Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance
- (2013) Johan W. E. Jocken et al. DIABETOLOGIA
- Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study
- (2013) Ho Cheol Hong et al. HEPATOLOGY
- Insulin-Like Growth Factor-I, Inflammatory Proteins, and Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease
- (2013) Marta Letizia Hribal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
- (2013) Hui-Jie Zhang et al. JOURNAL OF HEPATOLOGY
- The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
- (2013) Darlene E. Berryman et al. Nature Reviews Endocrinology
- The GH/IGF-1 axis in ageing and longevity
- (2013) Riia K. Junnila et al. Nature Reviews Endocrinology
- Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF- B-mediated mechanism
- (2013) J. Qiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis
- (2012) Jia Qiu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease
- (2012) Sunmi Kim et al. BMC GASTROENTEROLOGY
- Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver [Review]
- (2012) Yutaka Takahashi ENDOCRINE JOURNAL
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients
- (2011) Edith Koehler et al. LIVER INTERNATIONAL
- Menopause and sarcopenia: A potential role for sex hormones
- (2011) Virginie Messier et al. MATURITAS
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Elevated Myostatin Levels in Patients with Liver Disease
- (2010) Paul S. García et al. ANESTHESIA AND ANALGESIA
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Oxidative Stress, Molecular Inflammation and Sarcopenia
- (2010) Si-Jin Meng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III
- (2010) Preethi Srikanthan et al. PLoS One
- Understanding sarcopenia as a geriatric syndrome
- (2009) Alfonso J Cruz-Jentoft et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started